CClinicalTrials.gg
Not yet recruitingNCT07845474Updated Sep 29, 2026

A Manualized Recreational Therapy Balance Program for Older Adults With Parkinson's and Movement Disorders

An interventional study of Manualized recreational therapy balance program in Parkinson Disease (PD), Postural Balance, Movement Disorders (Incl Parkinsonism) and Postural Balance, sponsored by Oklahoma State University. Not yet recruiting at 1 site in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Oklahoma State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

This study evaluates a manualized recreational therapy balance program for older adults with Parkinson's disease and movement disorders who live in small cities and rural areas of Oklahoma, where access to movement disorder specialists is limited.

Twenty-four older adults with Parkinson's disease and movement disorders will be randomly assigned to one of two groups of 12. One group will attend the balance program continuously for 24 weeks. The other group will attend the program for 12 weeks and will then be observed for 12 weeks without the program. All sessions are led by a Certified Therapeutic Recreation Specialist and last about 50 minutes once a week.

Participants will be assessed three times: before the program begins, at three months, and at six months. The assessments measure gait velocity and stride length, postural stability, fall-related confidence, anxiety and depression, and social connectedness.

The purpose of the study is to learn how long a community balance program needs to continue for older adults to keep the gains they make, and how quickly those gains decline when the program ends.

Read the detailed description

Parkinson's disease and movement disorders accelerate physical decline. In Oklahoma, more than 15,000 residents have Parkinson's disease, and about one-third live in rural areas. Rural isolation restricts access to movement disorder specialists, and fewer than 30% of individuals with Parkinson's disease engage in regular physical activity. Rural patients face barriers including limited transportation, fear of injury, and a lack of local programs or peer support.

This study evaluates a manualized recreational therapy balance protocol that was developed with funding from the American Parkinson Disease Association (FY2025-1461556). The evaluation is designed to determine the dosage of community-based exercise required to promote sustained mobility and to prevent the physical regression often seen after a program ends.

Design. Twenty-four older adults diagnosed with Parkinson's disease and movement disorders will be randomly assigned to two equal cohorts of 12 in a two-cohort comparative evaluation. Cohort 1 will receive the continuous in-person intervention for six months (24 weeks). Cohort 2 will receive the intervention for three months (12 weeks), followed by a three-month observation period intended to quantify the decay of training effects.

Setting. The intervention is delivered in person at Legacy Village of Stillwater, Oklahoma.

Participants. Participants must be able to tolerate a 50-minute physical session once per week.

Intervention. All sessions follow a manualized recreational therapy balance protocol and are directed by a Certified Therapeutic Recreation Specialist. The program includes static and dynamic balance training.

Assessments. Data are collected by a Certified Therapeutic Recreation Specialist and research assistants at baseline, month three, and month six. The GAITRite system (CIR Systems, New Jersey, USA) measures gait velocity and stride length. The BioSway system (Biodex Medical Systems, New York, USA) quantifies postural stability. Secondary outcomes are measured with the Short Falls Efficacy Scale-International for fall-related self-efficacy, the Hospital Anxiety and Depression Scale for psychological states, and the Lubben Social Network Scale for social connectedness.

Research questions. (1) Does a 24-week continuous manualized recreational therapy balance program yield higher retention of postural stability and gait velocity compared with a 12-week intervention followed by a 12-week observation period in adults with Parkinson's disease? (2) How do the two intervention durations differ in sustaining fall-related self-efficacy, reducing anxiety, and building social connectedness at the six-month benchmark? (3) What duration of CTRS-led community intervention establishes lasting independence for patients lacking access to movement disorder specialists?

Hypotheses. (1) The 24-week cohort retains baseline posture and gait velocity at month six, while the 12-week cohort experiences regression. (2) The 24-week cohort sustains fall confidence, reduces anxiety, and builds group bonds at month six. (3) The 24-week duration establishes the threshold for lasting patient independence.

Analysis. Analysis is conducted in collaboration with the Oklahoma State University Physical Activity and Public Health Lab using a two-way repeated-measures analysis of variance across three time points (baseline, week 12, and week 24), comparing the continuous cohort with the abbreviated cohort.

02

Conditions studied

  • Parkinson Disease (PD), Postural Balance
  • Movement Disorders (Incl Parkinsonism)
  • Postural Balance
  • Accidental Falls

Keywords

  • recreational therapy
  • balance training
  • fall prevention
  • gait velocity
  • postural stability
  • rural health
  • community-based intervention
  • older adults
03

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of Parkinson's disease or another movement disorder
  • Able to tolerate a 50-minute physical activity session once per week
  • Able to attend in-person sessions at the study site
  • Willing and able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Medical condition that prevents safe participation in balance exercise
  • Unable to attend the weekly in-person sessions
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    24-week continuous balance program

    Participants attend the manualized recreational therapy balance program continuously for 24 weeks. Sessions are led by a Certified Therapeutic Recreation Specialist, last approximately 50 minutes, and are held once per week at Legacy Village of Stillwater. Sessions include static and dynamic balance training. Assessments are conducted at baseline, month three, and month six.

    Behavioral: Manualized recreational therapy balance program

  • Active comparator
    12-week balance program followed by 12-week observation

    Participants attend the same manualized recreational therapy balance program for 12 weeks under the same schedule and format, and then enter a 12-week observation period during which the program is not provided. Assessments are conducted at baseline, month three, and month six.

    Behavioral: Manualized recreational therapy balance program

Interventions

  • BehavioralManualized recreational therapy balance program

    A manualized balance training protocol delivered in person by a Certified Therapeutic Recreation Specialist in approximately 50-minute weekly sessions, including static and dynamic balance training. The protocol was developed with funding from the American Parkinson Disease Association.

05

What researchers measure

Primary outcomes

  1. Change in gait velocity measured by the GAITRite system

    Gait velocity in centimeters per second measured with the GAITRite electronic walkway (CIR Systems, New Jersey, USA). Higher values indicate faster walking.

    Time frame: Baseline, 12 weeks, 24 weeks

Secondary outcomes

  1. Change in postural stability measured by the BioSway system

    Postural stability measured with the BioSway balance system (Biodex Medical Systems, New York, USA). Higher sway values indicate poorer postural stability.

    Time frame: Baseline, 12 weeks, 24 weeks

  2. Change in fall-related self-efficacy measured by the Short Falls Efficacy Scale-International (Short FES-I)

    Seven-item scale scored from 7 to 28. Higher scores indicate greater concern about falling.

    Time frame: Baseline, 12 weeks, 24 weeks

  3. Change in anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS)

    Fourteen-item scale scored from 0 to 42. Higher scores indicate greater anxiety and depressive symptoms.

    Time frame: Baseline, 12 weeks, 24 weeks

  4. Change in social connectedness measured by the Lubben Social Network Scale (LSNS)

    Scale measuring perceived social network size and support. Higher scores indicate greater social connectedness.

    Time frame: Baseline, 12 weeks, 24 weeks

06

Study locations

1 site
  • Legacy Village of Stillwater
    Stillwater, Oklahoma 74074, United States
07

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly. The IRB-approved protocol and informed consent documents do not include provisions for sharing individual participant data outside the research team. De-identified aggregate results will be reported in peer-reviewed publications.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07845474
Lead sponsor
Oklahoma State University
Responsible party
JungyuLee (Postdoctoral Fellow, Oklahoma State University) — Principal investigator
First posted
Sep 29, 2026
Start date
Oct 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
May 13, 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Jungyu Lee, PhD
Contact
jungyu.lee@okstate.edu
405-762-1844
Tim Passmore, Ed.D.
Contact
tim.passmore@okstate.edu
405-744-1811

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion